Prof Susan Clark elected Fellow of the Australian Academy of Science
Recent Posts
Spotlight on: Melanie Eckersley-Maslin 25 November 2022
Spotlight on: Jessamy Tiffen 25 July 2022
ECR Spotlight on: Alex Woodworth 16 July 2022
Epigenetics 2022: Four weeks left for poster abstract submissions! 15 July 2022
Emma Whitelaw ECR Publication Award 30 June 2022
Epigenetics 2022 – Meet the speakers 17 June 2022
ECR Spotlight on: Kate Giles 31 May 2022
Spotlight on: Luciano Martelotto 30 May 2022
Epigenetics 2022 speakers announced 20 April 2022
Spotlight on: Hamish King 18 April 2022
ECR Spotlight on: William Schierding 6 April 2022
Spotlight on: Louise Bicknell 14 March 2022
Categories
News (57)
Opportunities (3)
Publications (7)
Spotlight on … (16)
World epi news (2)
Archived news
2022 (12)
2021 (9)
2020 (9)
2019 (1)
2018 (6)
2017 (6)
2016 (6)
2015 (17)
2014 (1)
by AEpiA| May 26, 2015 | News
Congratulations to our AEpiA President, Professor Susan Clark, who has been elected Fellow of the Australian Academy of Science in recognition of her outstanding contributions to science and scientific research.
Professor Clark is one of 21 new fellows, 9 women and 12 men, to be elected in 2015 from around Australia and across all the natural sciences. The Academy now numbers a total of 503 Fellows.
Head of the Genomics and Epigenetics Division at the Garvan Institute of Medical Research in Sydney, Professor Clark is highly acclaimed internationally for her work in human epigenetics, and is best known for her pivotal contribution to the advancement of new sequencing technologies for DNA methylation and histone modification to investigate complex relationships between epigenetic alterations and gene control in normal and cancer cells.
The techniques pioneered by Professor Clark in the early 1990s, including bisulphite sequencing, have revolutionised and now underpin the new era in epigenomic research. Her discoveries relating to DNA methylation patterns in normal and cancer genomes have led to the commercialisation of new methylation-based tests for early cancer detection.
Professor Clark’s research has initiated profound questions about the importance of epigenetics in early development and disease, especially in cancer. Within the last five years, she has demonstrated that epigenetic changes in cancer are not restricted to individual genes but can encompass genome-wide domains, resulting in widespread gene silencing and activation.
As well as leading the formation of the AEpiA, Professor Clark was also a founding member of the International Human Epigenome Consortium (IHEC).
“The Australian Academy of Science is the most highly regarded scientific body in Australia,” said Professor Clark. “I am extremely honoured and humbled to be elected as a Fellow.”